Sanofi appoints Jean-Paul Kress as Independent Director Ruchika Sharma21 Dec 2024 12:30 PM ISTParis: Sanofi has announced the appointment of Jean-Paul Kress as an Independent Director, effective January 1, 2025. Jean-Paul Kress will...
AstraZeneca to acquire Amolyt Pharma for USD 1.05 billion Susmita Roy15 March 2024 2:17 PM ISTCambridge: AstraZeneca has announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology...
AstraZeneca rare disease unit acquires Pfizer portfolio for USD 1 billion Ruchika Sharma22 Sept 2023 2:25 PM ISTAstraZeneca's Rare-Disease Unit
AstraZeneca Rare Disease arm enters agreement with Pfizer to acquire portfolio of preclinical rare disease gene therapies Ruchika Sharma30 July 2023 3:30 PM ISTUnder the agreement, Alexion will purchase and licence the assets of Pfizer's early-stage rare disease gene therapy portfolio for a total...
AstraZeneca Rare Disease, Alexion to acquire LogicBio Therapeutics to accelerate growth in Genomic Medicine Ruchika Sharma4 Oct 2022 11:45 AM ISTAlexion, through a subsidiary, will initiate a cash tender offer to acquire all outstanding shares of LogicBio for $2.07 per share.
AstraZeneca Covid jab Vaxzevria sales slide Ruchika Sharma1 Aug 2022 1:10 PM ISTThe group said annual revenue from Covid-19 medicines is anticipated to be broadly flat compared with 2021.
AstraZeneca and Neurimmune collaborate to develop and commercialize NI006 MD Bureau2 March 2022 1:15 PM ISTNI006 is an investigational human monoclonal antibody that specifically targets misfolded transthyretin.
AstraZeneca arm halts trial on neurological disorder treatment Ruchika Sharma22 Aug 2021 9:15 AM ISTNew Delhi: AstraZeneca's Alexion division will stop developing a treatment for the neurological disorder ALS due to lack of efficacy in a late-stage...
